Avenue Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Net Income	-7.18	-10.38	-3.55	-3.73	-5.15	-25.91	Upgrade
Share-Based Compensation	1.09	0.91	0.65	0.44	0.71	1.84	Upgrade
Other Operating Activities	-4.9	0.02	-4.69	-0.46	-0.17	-2.19	Upgrade
Operating Cash Flow	-11	-9.45	-7.6	-3.75	-4.61	-26.26	Upgrade
Capital Expenditures	0	0	0	0	-1	0	Upgrade
Other Investing Activities	-1	-3	-	-	-	-	Upgrade
Investing Cash Flow	-1	-3	0	0	-1	0	Upgrade
Share Issuance / Repurchase	4.43	7.53	10.54	5.04	0	35	Upgrade
Other Financing Activities	4.53	-	-	-0.66	-	-2.67	Upgrade
Financing Cash Flow	8.96	7.53	10.54	4.38	0	32.33	Upgrade
Net Cash Flow	-5.04	-4.93	2.95	0.63	-5.61	6.07	Upgrade
Free Cash Flow	-11	-9.45	-7.6	-3.75	-5.61	-26.26	Upgrade
Free Cash Flow Per Share	-19.57	-66.92	-260.71	-248.20	-382.54	-1878.93	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).